These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 33931648)
1. A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia. Docking TR; Parker JDK; Jädersten M; Duns G; Chang L; Jiang J; Pilsworth JA; Swanson LA; Chan SK; Chiu R; Nip KM; Mar S; Mo A; Wang X; Martinez-Høyer S; Stubbins RJ; Mungall KL; Mungall AJ; Moore RA; Jones SJM; Birol İ; Marra MA; Hogge D; Karsan A Nat Commun; 2021 Apr; 12(1):2474. PubMed ID: 33931648 [TBL] [Abstract][Full Text] [Related]
2. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis. Zhu F; Huang R; Li J; Liao X; Huang Y; Lai Y Med Sci Monit; 2018 Oct; 24():7100-7108. PubMed ID: 30289875 [TBL] [Abstract][Full Text] [Related]
3. A Novel 85-Gene Expression Signature Predicts Unfavorable Prognosis in Acute Myeloid Leukemia. Lai Y; Sheng L; Wang J; Zhou M; OuYang G Technol Cancer Res Treat; 2021; 20():15330338211004933. PubMed ID: 33784904 [TBL] [Abstract][Full Text] [Related]
4. A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients. Wang F; Tian X; Zhou J; Wang G; Yu W; Li Z; Fan Z; Zhang W; Liang A Mol Med Rep; 2018 Aug; 18(2):1473-1484. PubMed ID: 29901168 [TBL] [Abstract][Full Text] [Related]
5. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia. Shiba N; Yoshida K; Hara Y; Yamato G; Shiraishi Y; Matsuo H; Okuno Y; Chiba K; Tanaka H; Kaburagi T; Takeuchi M; Ohki K; Sanada M; Okubo J; Tomizawa D; Taki T; Shimada A; Sotomatsu M; Horibe K; Taga T; Adachi S; Tawa A; Miyano S; Ogawa S; Hayashi Y Blood Adv; 2019 Oct; 3(20):3157-3169. PubMed ID: 31648321 [TBL] [Abstract][Full Text] [Related]
6. The Transcriptome Study of Subtype M2 Acute Myeloblastic Leukemia. Wu AY; Yang HC; Lin CM; Wu BD; Qu QS; Zheng YH; Wei H; Mei XQ; Zeng ZH; Ma XD Cell Biochem Biophys; 2015 Jul; 72(3):653-6. PubMed ID: 27352183 [TBL] [Abstract][Full Text] [Related]
7. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia. Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328 [TBL] [Abstract][Full Text] [Related]
8. Full-length mutation search of the TP53 gene in acute myeloid leukemia has increased significance as a prognostic factor. Terada K; Yamaguchi H; Ueki T; Usuki K; Kobayashi Y; Tajika K; Gomi S; Kurosawa S; Miyadera K; Tokura T; Omori I; Marumo A; Fujiwara Y; Yui S; Ryotokuji T; Osaki Y; Arai K; Kitano T; Kosaka F; Wakita S; Tamai H; Fukuda T; Inokuchi K Ann Hematol; 2018 Jan; 97(1):51-61. PubMed ID: 28980058 [TBL] [Abstract][Full Text] [Related]
9. Control of focal adhesion kinase activation by RUNX1-regulated miRNAs in high-risk AML. Akhade VS; Liu T; Docking TR; Jiang J; Gopal A; Karsan A Leukemia; 2023 Apr; 37(4):776-787. PubMed ID: 36788336 [TBL] [Abstract][Full Text] [Related]
10. Identification of the Thyrotropin-Releasing Hormone (TRH) as a Novel Biomarker in the Prognosis for Acute Myeloid Leukemia. Gao Y; Zhou JF; Mao JY; Jiang L; Li XP Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291567 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing. Arindrarto W; Borràs DM; de Groen RAL; van den Berg RR; Locher IJ; van Diessen SAME; van der Holst R; van der Meijden ED; Honders MW; de Leeuw RH; Verlaat W; Jedema I; Kroes WGM; Knijnenburg J; van Wezel T; Vermaat JSP; Valk PJM; Janssen B; de Knijff P; van Bergen CAM; van den Akker EB; Hoen PAC'; Kiełbasa SM; Laros JFJ; Griffioen M; Veelken H Leukemia; 2021 Jan; 35(1):47-61. PubMed ID: 32127641 [TBL] [Abstract][Full Text] [Related]
12. Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells. Morita K; Noura M; Tokushige C; Maeda S; Kiyose H; Kashiwazaki G; Taniguchi J; Bando T; Yoshida K; Ozaki T; Matsuo H; Ogawa S; Liu PP; Nakahata T; Sugiyama H; Adachi S; Kamikubo Y Sci Rep; 2017 Nov; 7(1):16604. PubMed ID: 29192243 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group. Noort S; Zimmermann M; Reinhardt D; Cuccuini W; Pigazzi M; Smith J; Ries RE; Alonzo TA; Hirsch B; Tomizawa D; Locatelli F; Gruber TA; Raimondi S; Sonneveld E; Cheuk DK; Dworzak M; Stary J; Abrahamsson J; Arad-Cohen N; Czogala M; De Moerloose B; Hasle H; Meshinchi S; van den Heuvel-Eibrink M; Zwaan CM Blood; 2018 Oct; 132(15):1584-1592. PubMed ID: 30150206 [TBL] [Abstract][Full Text] [Related]
15. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing. Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340 [TBL] [Abstract][Full Text] [Related]
16. DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia. Masetti R; Togni M; Astolfi A; Pigazzi M; Manara E; Indio V; Rizzari C; Rutella S; Basso G; Pession A; Locatelli F Oncotarget; 2013 Oct; 4(10):1712-20. PubMed ID: 24127550 [TBL] [Abstract][Full Text] [Related]
17. The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia. Duployez N; Marceau-Renaut A; Villenet C; Petit A; Rousseau A; Ng SWK; Paquet A; Gonzales F; Barthélémy A; Leprêtre F; Pottier N; Nelken B; Michel G; Baruchel A; Bertrand Y; Leverger G; Lapillonne H; Figeac M; Dick JE; Wang JCY; Preudhomme C; Cheok M Leukemia; 2019 Feb; 33(2):348-357. PubMed ID: 30089916 [TBL] [Abstract][Full Text] [Related]
18. Wilms Tumor 1 Expression at Diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia: A Hokkaido Leukemia Net Study. Hidaka D; Onozawa M; Hashiguchi J; Miyashita N; Kasahara K; Fujisawa S; Hayase E; Okada K; Shiratori S; Goto H; Sugita J; Nakagawa M; Hashimoto D; Kahata K; Endo T; Yamamoto S; Tsutsumi Y; Haseyama Y; Nagashima T; Mori A; Ota S; Sakai H; Ishihara T; Imai K; Miyagishima T; Kakinoki Y; Kurosawa M; Kobayashi H; Iwasaki H; Shimizu C; Kondo T; Teshima T Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e469-e479. PubMed ID: 30082223 [TBL] [Abstract][Full Text] [Related]
19. Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia. Cheng WY; Li JF; Zhu YM; Lin XJ; Wen LJ; Zhang F; Zhang YL; Zhao M; Fang H; Wang SY; Lin XJ; Qiao N; Yin W; Zhang JN; Dai YT; Jiang L; Sun XJ; Xu Y; Zhang TT; Chen SN; Zhu HH; Chen Z; Jin J; Wu DP; Shen Y; Chen SJ Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2211429119. PubMed ID: 36442087 [TBL] [Abstract][Full Text] [Related]
20. Identification of distinctive long noncoding RNA competitive interactions and a six-methylated-gene prognostic signature in acute myeloid leukemia with -5/del(5q) or -7/del(7q). Yin X; Huang S; Xu A; Fan F; Chen L; Sun C; Hu Y J Cell Biochem; 2020 Feb; 121(2):1563-1574. PubMed ID: 31535409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]